Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Grandfield & Dodd LLC Sells 28,306 Shares of Gilead Sciences, Inc. $GILD
Jupiter Asset Management Ltd. Increases Holdings in Gilead Sciences, Inc. $GILD - Zolmax
Koss Olinger Consulting LLC Sells 13,702 Shares of Gilead Sciences, Inc. $GILD
Savant Capital LLC Has $3.32 Million Position in Gilead Sciences, Inc. $GILD
Norges Bank Takes Position in Gilead Sciences, Inc. $GILD
Eurizon Capital SGR S.p.A. Invests $117.43 Million in Gilead Sciences, Inc. $GILD
Triglav Investments D.O.O. Grows Stock Position in Gilead Sciences, Inc. $GILD - Daily Political
Gilead Sciences (GILD) Valuation Check After Hepcludex Wins First FDA Approval For Hepatitis Delta
Best Pharmaceutical Stocks To Research - May 29th - Daily Political
Gilead Sciences, Inc. $GILD Shares Sold by Ilmarinen Mutual Pension Insurance Co
13,211 Shares in Gilead Sciences, Inc. $GILD Acquired by SBI Okasan Asset Management Co.Ltd. - Stock Observer
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Purchases 424,796 Shares of Gilead Sciences, Inc. $GILD - Stock Observer
Gilead (GILD) Wins FDA Approval for First HDV Treatment Hepcludex
National Pension Service Reduces Position in Gilead Sciences, Inc. $GILD - Daily Political
Gilead Sciences Inc at Bernstein Strategic Decisions Conference Transcript
Novel Spanish, Culturally Adapted Metastatic Breast Cancer Symptom Management Guide Debuts at ASCO 2026
Harbour Investments Inc. Boosts Holdings in Gilead Sciences, Inc. $GILD
Geode Capital Management LLC Sells 232,984 Shares of Gilead Sciences, Inc. $GILD
Eukles Asset Management Cuts Position in Gilead Sciences, Inc. $GILD
Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology Portfolio
GILD scores FDA win for HDV drug, CHMP backs Trodelvy
Todd Asset Management LLC Increases Stake in Gilead Sciences, Inc. $GILD
May 2026's Top Stocks That Could Be Trading Below Estimated Fair Value - Simply Wall St News
Gilead Sciences, Inc. $GILD Shares Sold by Simplify Asset Management Inc. - Zolmax
Simplify Asset Management Inc. Lowers Stake in Gilead Sciences, Inc. $GILD
Legal & General Group Plc Acquires 107,014 Shares of Gilead Sciences, Inc. $GILD - Stock Observer
Zacks Research Expects Lower Earnings for Gilead Sciences
Maxim Upgrades Gilead Sciences (GILD) to 'Buy'
Gilead Sciences Highlights Trodelvy Lung Data, Long-Acting HIV Pipeline at RBC Conference
Gilead Sciences, Inc. (NASDAQ:GILD) Given Average Recommendation of "Moderate Buy" by Brokerages
Gilead Sciences, Inc. $GILD Shares Sold by GPS Wealth Strategies Group LLC - Zolmax
LSV Asset Management Has $508.91 Million Position in Gilead Sciences, Inc. $GILD
Global Retirement Partners LLC Grows Position in Gilead Sciences, Inc. $GILD - Stock Observer
Experimental treatments could help US Ebola patient
GILD Receives FDA Approval for Hepcludex, First Treatment for Chronic HDV Infection
Gilead Sciences Gets FDA Green Light for Chronic HDV Drug | Morningstar
US FDA approves Gilead's drug for deadly liver infection - AOL
US FDA approves Gilead's drug for deadly liver infection - Yahoo News Canada
FDA Grants Accelerated Approval to Gilead's Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus (HDV)
GILD: Gilead's Trodelvy Gains Positive Opinion for TNBC Treatment in Europe
Gilead Gets Positive Opinion From European Regulators on Breast-Cancer Treatment | Morningstar
Gilead Receives CHMP Positive Opinion for Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer for Patients Not Candidates for PD-(L)1 Inhibitors
Zacks Research Forecasts Weaker Earnings for Gilead Sciences
PNC Financial Services Group Inc. Buys 53,135 Shares of Gilead Sciences, Inc. $GILD - Stock Observer
- ASCO Presentations on Trodelvy ® in First-line Metastatic
Gilead Sciences (GILD) Is Among The Best Extremely Profitable Stocks To Buy According To Wall Street Analysts
Forget Moderna: This Biotech Juggernaut Is a Way Better Buy Right Now
Gilead Sciences Completes Acquisition of Tubulis Further Strengthening Oncology Portfolio
Hepatic Impairment Market Analysis Report 2026-2036 Featuring AbbVie, Astellas Pharma, Gilead Sciences, F. Hoffmann La Roche, and Takeda Pharmaceuticals
GILD Partners with WHO to Combat Visceral Leishmaniasis
Leonteq Securities AG Takes Position in Gilead Sciences, Inc. $GILD - Daily Political
Gilead Sciences (GILD) Announces Issuance of Senior Notes in New Indenture Agreement
How Investors May Respond To Gilead Sciences (GILD) Multi‑Billion Laddered Bond Issuance And Capital Plan
GILD Maintains a $122 Price Target Following Healthcare Conference
Gilead Sciences (NASDAQ:GILD) Upgraded to Buy at Maxim Group
Morgan Stanley Reassesses Gilead Sciences (GILD) Outlook Following Quarterly Report
Gilead Sciences, Inc. $GILD Shares Sold by Mitsubishi UFJ Asset Management UK Ltd.
Banque Cantonale Vaudoise Has $8.71 Million Stock Position in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Sold by Banque Cantonale Vaudoise
Atle Fund Management AB Sells 27,373 Shares of Gilead Sciences, Inc. $GILD
Envestnet Portfolio Solutions Inc. Boosts Position in Gilead Sciences, Inc. $GILD - Daily Political
Atle Fund Management AB Has $6.24 Million Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political
Cost-effectiveness of community interventions to promote awareness, testing and treatment of hepatitis B and C in migrant populations in Catalonia
5 Best Long Term Low Risk Stocks to Buy According to Hedge Funds
Attractive medium-term compounder with catalyst-rich profile, but with short-term volatility tied to investment phase
ProShare Advisors LLC Buys 623,752 Shares of Gilead Sciences, Inc. $GILD
Profund Advisors LLC Buys 15,824 Shares of Gilead Sciences, Inc. $GILD
HighTower Advisors LLC Lowers Stake in Gilead Sciences, Inc. $GILD - Zolmax
HighTower Advisors LLC Decreases Stake in Gilead Sciences, Inc. $GILD
RBC Capital Sticks to Its Hold Rating for aTyr Pharma (ATYR)
Optimising patient centred drug development to realise impact
Gilead Sciences (NASDAQ:GILD) Insider Sells $3,676,120.00 in Stock
Hepatic Cirrhosis Market Research and Forecast Report 2026-2036, Profiles of Abbott, Astellas Pharma, Gilead Sciences, Novartis, Takeda Pharma, Grifols Therapeutics, and Cellaion
45,461 Shares in Gilead Sciences, Inc. $GILD Purchased by North Dakota State Investment Board
Erste Group Bank Predicts Gilead Sciences FY2026 Earnings
Top Pharmaceutical Stocks To Keep An Eye On - May 17th - Stock Observer
Gilead Sciences Leans on HIV Growth as Deals Build Oncology, Inflammation Pipeline
Leuthold Group LLC Boosts Stake in Gilead Sciences, Inc. $GILD
L & S Advisors Inc Invests $5.09 Million in Gilead Sciences, Inc. $GILD
STF Management LP Sells 11,745 Shares of Gilead Sciences, Inc. $GILD
iA Global Asset Management Inc. Increases Position in Gilead Sciences, Inc. $GILD
Gilead Sciences, Inc. $GILD Shares Sold by Canada Post Corp Registered Pension Plan
Abacus Wealth Partners LLC Buys Shares of 12,486 Gilead Sciences, Inc. $GILD
Bank Julius Baer & Co. Ltd Zurich Sells 4,174 Shares of Gilead Sciences, Inc. $GILD - Stock Observer
Gilead Sciences, Inc. $GILD Shares Sold by STF Management LP - Daily Political
AlphaCore Capital LLC Increases Stock Position in Gilead Sciences, Inc. $GILD - Stock Observer
Gilead Sciences, Inc. $GILD Position Lessened by Canada Post Corp Registered Pension Plan - Daily Political
Abacus Wealth Partners LLC Makes New $1.53 Million Investment in Gilead Sciences, Inc. $GILD - Daily Political
Evaluating Gilead Sciences (GILD) Valuation After Q1 Beat Guidance Shift And New HIV Priority Review
Lawood & Co. Invests $633,000 in Gilead Sciences, Inc. $GILD - Zolmax
A Look At Gilead Sciences (GILD) Valuation After The Recent Share Price Pullback
Gilead News
Markets.com vs eToro: Key Differences Every South Africa CFD Trader Should Know
Markets.com Review 2026: Complete Account Opening Guide, Deposit, Withdrawal & Demo Test
S&P 500 Analysis: S&P 500 Trading Landscape Changes as Wall Street Reacts to Economic Data
Latest news
Show more
Islamic Green Finance: Dubai Islamic Bank Launches $500mn Green Sukuk to Fund Sustainable Projects
Gold Price Today, May 29: XAUUSD Holds Steady Above $4,500 Amid Market Volatility
JSE Resilience Amid Volatility: Key Stock Moves and Market Outlook for May 2026
Gold Price Today, May 28: Gold Tests Key Support Near $4,440 Amid Fed and Yield Pressures
Oil Price Today: Middle East Tensions Push Oil Above $100, European Energy Stocks Surge on Higher Crude
UAE’s Explosive AI Growth: UAE Tops Global AI Adoption for Third Straight Quarter at 70.1% Usage Rate
